Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:19 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 1,726 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Physical Activity Level Clear all

Conditions: Inflammatory Response
Interventions: Eccentric leg extension; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Phantom Limb Pain
Interventions: M1 anodal home-based tDCS, Somatosensory Training, Usual Care; Device · Behavioral · Other
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years and older
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Graft Versus Host Disease
Interventions: Bortezomib; Drug
Lead sponsor: Mehrdad Abedi, MD; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Amputation
Interventions: Prosthetic/Bicycle Configuration; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Aripiprazole, Olanzapine, Paliperidone, Quetiapine, Risperidone; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 3
States / cities: Torrance, California • Kissimmee, Florida • Conshohocken, Pennsylvania

Conditions: Thalassemia
Interventions: Exercise; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 14 Years to 40 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Oakland, California

Conditions: Lower Limb Amputation Below Knee
Interventions: As-prescribed stiffness, Two categories stiffer than the as-prescribed stiffness, Two categories less stiff than the as-prescribed stiffness; Device
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 18 Years to 70 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Tracheobronchomalacia
Interventions: Bethanechol; Drug
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: Not listed
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Crohn's Disease
Interventions: PF-00547659 SC injection; Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 265 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 69
States / cities: Jonesboro, Arkansas • Little Rock, Arkansas • La Jolla, California + 38 more

Conditions: Sarcoma
Interventions: Interview, Observations, Guided Activities; Behavioral
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 7 Years to 11 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Advanced Cancer
Interventions: Caregiver-guided pain management training (CG-PMT), Enhanced treatment-as-usual (TAU); Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Post-Traumatic Stress Disorder
Interventions: Behavioral Activation; Behavioral
Lead sponsor: VA Puget Sound Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Reintegration
Interventions: Vigorous Intensity Aerobic Exercise and Community Engagement, Community Engagement; Other
Lead sponsor: Jasper A. Smits; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: NIP292 tablet, NIP292 tablets; Drug
Lead sponsor: The National Institutes of Pharmaceutical R&D Co. Ltd, China; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Glendale, California

Conditions: Pelvic Organ Prolapse
Interventions: FemmeJock; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Daily Report Card, Language Intervention; Behavioral · Other
Lead sponsor: Florida International University; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Stuttering, Developmental, Aphasia, Primary Progressive
Interventions: Learning of non-native phoneme combinations: 6 training sessions, Learning of non-native phoneme combinations: 1 training session, Learning of novel multisyllabic nonwords, Anodal tDCS, Sham tDCS, Learning of non-native phoneme combinations: 8 training sessions; Behavioral · Other
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 6 Years and older
Enrollment: 278 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 3
States / cities: Boston, Massachusetts • Ann Arbor, Michigan

Conditions: Cancer of Prostate
Interventions: ADT ORDER CHECK ATTESTATION (OR), PROVIDER SCRIPT (SC); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: HER2-Positive Solid Tumor
Interventions: YH32367; Drug
Lead sponsor: Yuhan Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 2
States / cities: Boston, Massachusetts • Nashville, Tennessee

Conditions: Physical Activity
Interventions: Group; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 35 Years to 64 Years
Enrollment: 308 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Waldenstrom's Macroglobulinemia
Interventions: Ulocuplumab, Ibrutinib; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Diseases, Hypertension, Postmenopausal, Overweight or Obese
Interventions: Exercise; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 45 Years to 75 Years · Female only
Enrollment: 464 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: NASH, Fatty Liver, NAFLD, Weight Loss
Interventions: Noom Healthy Weight Program; Behavioral
Lead sponsor: Noom Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chandler, Arizona

Conditions: Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
Interventions: Exercise Intervention, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration; Behavioral · Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise

Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response

Bortezomib in Patients With Chronic Graft Versus Host Disease

Optimizing Prosthetic and Bicycle Fit for Veterans With Transtibial Amputations

A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Effect of Exercise on Body Composition and Bone Health in Patients With Thalassemia

Automatic Prosthetic Foot Stiffness Modulation to Improve Balance

The Effect of Bethanechol on Tracheobronchomalacia

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease

A Qualitative Case Study of the Experiences of Children With Cancer as They Learn About Their Diagnosis and Treatment

Caregiver-Guided Pain Management Training in Palliative Care

Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)

Physical Activity and Community Engagement (PACE) Among Returning Veterans

A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

The Purpose of This Study is to Look at Pelvic Support Problems, Also Commonly Known as Pelvic Organ Prolapse

Interventions for English Language Learners At-Risk for ADHD

Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech

De-implementation of Low Value Castration for Men With Prostate Cancer

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

WalkLink: Internet-based Walking Program

A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia

Dose-Response to Exercise in Women Aged 45-75 Years (DREW)

Effects of Online App Weight Loss Programs on Liver Health in Obese Adults

High-Intensity Interval Training for Stage I-III Breast Cancer Patients